The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway
Liang He, Ting Zhang, Wei Sun, Yuan Qin, Zhihong Wang, Wenwu Dong, Hao Zhang
Topics & Concepts
SaxagliptinCancer researchGene silencingThyroid cancerThyroid carcinomaChemistryInternal medicineEndocrinologyBiologyThyroidMedicineBiochemistryDiabetes mellitusType 2 diabetesGeneSitagliptinPeptidase Inhibition and AnalysisDiabetes Treatment and ManagementGalectins and Cancer Biology